Since E2F1 plays an important role in cardiac myocyte growth and is also involved in metabolism regulation through PDK4 modulation, targeting this transcription factor could provide us with an effective therapy for treating detrimental left ventricular hypertrophy leading to heart failure. The gene discussed is E2F1; the disease is left ventricular hypertrophy.